In this study, we calculated the proportion of tumor-infiltrating immune cells (TICs) and the proportion of immune and matrix components of BC samples from The Cancer Genome Atlas (TCGA) database and determined a useful predictive biomarker CD52. Here, CD52 is linked to neoplasm.